A Longitudinal Study of Genital Human Papillomavirus Infection in a Cohort of Closely Followed Adolescent Women

Overview

Journal J Infect Dis

Publisher Oxford University Press

Specialty Infectious Diseases

Date 2004 Dec 21

PMID 15609227

Citations 115

Authors

Darron R Brown

Marcia L Shew

Brahim Qadadri

Nicole Neptune

Maria Vargas

Wanzhu Tu

Beth E Juliar

Timothy E Breen

J Dennis Fortenberry

Affiliations

Soon will be listed here.

Abstract

Background: We performed a study to better characterize the natural history of genital human papillomavirus (HPV) infection in a cohort of closely followed adolescent women.

Methods: A cohort of 60 adolescent women was followed over a 2.2-year period, on average. A median of 41.5 self-collected vaginal and clinician-obtained cervical swabs were obtained from each subject.

Results: HPV was detected in 45.3% of all adequate specimens, by use of a polymerase chain reaction/reverse blot strip assay. Oncogenic--or high-risk (HR)--HPV types were detected in 38.6% of specimens, and nononcogenic--or low-risk (LR)--types were detected in 19.6% of specimens. During the entire study period, 49 of 60 subjects tested positive for HPV (cumulative prevalence, 81.7%). The most frequently detected HR types were HPV types 52, 16, and 59. Infections with multiple HPV types were common. The median duration of persistence of a specific HPV type was 168 days, and HR types were more persistent than LR types. Abnormal cervical cytological results occurred in 37% of the adolescent women and were significantly associated with HR HPV infection.

Conclusions: The cumulative prevalence of HPV infection in sexually active adolescent women is extremely high, involves numerous HPV types, and frequently results in cervical dysplasia.

Citing Articles

Looking Back, Moving Forward: Challenges and Opportunities for Global Cervical Cancer Prevention and Control.

Castle P Viruses. 2024; 16(9).

PMID: 39339834 PMC: 11435674. DOI: 10.3390/v16091357.

Understanding the Dynamics of Human Papillomavirus and Diagnostic Discrepancies in Cervical Pathology: A Single Center Experience.

Zamurovic M, Tomic A, Pikula A, Simanic S, Knezevic A, Jankovic M Diagnostics (Basel). 2023; 13(24).

PMID: 38132198 PMC: 10743259. DOI: 10.3390/diagnostics13243614.

Study on the prevalence and subtypes of human papillomavirus infection among women in the Xuhui District, Shanghai City, China.

Liu H, Zeng C, Jiang M, Dai Y, Xu M, Zhou F Transl Cancer Res. 2023; 12(10):2923-2931.

PMID: 37969362 PMC: 10643963. DOI: 10.21037/tcr-23-1491.

Outcome and associated factors of high-risk human papillomavirus infection without cervical lesions.

Feng T, Cheng B, Sun W, Yang Y BMC Womens Health. 2023; 23(1):599.

PMID: 37957634 PMC: 10644444. DOI: 10.1186/s12905-023-02764-8.

Association of plasma aflatoxin with persistent detection of oncogenic human papillomaviruses in cervical samples from Kenyan women enrolled in a longitudinal study.

Tong Y, Tonui P, Orango O, Zhang J, Maina T, Muthoka K BMC Infect Dis. 2023; 23(1):377.

PMID: 37280534 PMC: 10242809. DOI: 10.1186/s12879-023-08323-8.

References

Moscicki A, Ellenberg J, Vermund S, Holland C, Darragh T, Crowley-Nowick P . Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus. Arch Pediatr Adolesc Med. 2000; 154(2):127-34. DOI: 10.1001/archpedi.154.2.127. View

Gravitt P, Lacey Jr J, Brinton L, Barnes W, Kornegay J, Greenberg M . Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction. Cancer Epidemiol Biomarkers Prev. 2001; 10(2):95-100. View

Katz B, Fortenberry J, Tu W, Harezlak J, Orr D . Sexual behavior among adolescent women at high risk for sexually transmitted infections. Sex Transm Dis. 2001; 28(5):247-51. DOI: 10.1097/00007435-200105000-00001. View

Shah K, Daniel R, Tennant M, Shah N, McKee Jr K, Gaydos C . Diagnosis of human papillomavirus infection by dry vaginal swabs in military women. Sex Transm Infect. 2001; 77(4):260-4. PMC: 1744351. DOI: 10.1136/sti.77.4.260. View

Giuliano A, Harris R, Sedjo R, Baldwin S, Roe D, Papenfuss M . Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study. J Infect Dis. 2002; 186(4):462-9. DOI: 10.1086/341782. View

Brown D, Legge D, Qadadri B . Distribution of human papillomavirus types in cervicovaginal washings from women evaluated in a sexually transmitted diseases clinic. Sex Transm Dis. 2002; 29(12):763-8. DOI: 10.1097/00007435-200212000-00005. View

Sellors J, Karwalajtys T, Kaczorowski J, Mahony J, Lytwyn A, Chong S . Incidence, clearance and predictors of human papillomavirus infection in women. CMAJ. 2003; 168(4):421-5. PMC: 143547. View

Tarkowski T, Koumans E, Sawyer M, Pierce A, Black C, Papp J . Epidemiology of human papillomavirus infection and abnormal cytologic test results in an urban adolescent population. J Infect Dis. 2004; 189(1):46-50. DOI: 10.1086/380466. View

Sotlar K, Diemer D, Dethleffs A, Hack Y, Stubner A, Vollmer N . Detection and typing of human papillomavirus by e6 nested multiplex PCR. J Clin Microbiol. 2004; 42(7):3176-84. PMC: 446280. DOI: 10.1128/JCM.42.7.3176-3184.2004. View

10.

Moscicki A, Palefsky J, Smith G, Siboshski S, Schoolnik G . Variability of human papillomavirus DNA testing in a longitudinal cohort of young women. Obstet Gynecol. 1993; 82(4 Pt 1):578-85. View

11.

Asato T, Nakajima Y, Nagamine M, Nakashima Y, Takei H, Maehama T . Correlation between the progression of cervical dysplasia and the prevalence of human papillomavirus. J Infect Dis. 1994; 169(4):940-1. DOI: 10.1093/infdis/169.4.940. View

12.

Evander M, Edlund K, Gustafsson A, Jonsson M, Karlsson R, Rylander E . Human papillomavirus infection is transient in young women: a population-based cohort study. J Infect Dis. 1995; 171(4):1026-30. DOI: 10.1093/infdis/171.4.1026. View

13.

Brisson J, Bairati I, Morin C, Fortier M, Bouchard C, Christen A . Determinants of persistent detection of human papillomavirus DNA in the uterine cervix. J Infect Dis. 1996; 173(4):794-9. DOI: 10.1093/infdis/173.4.794. View

14.

Londesborough P, Ho L, Terry G, Cuzick J, Wheeler C, Singer A . Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer. 1996; 69(5):364-8. DOI: 10.1002/(SICI)1097-0215(19961021)69:5<364::AID-IJC2>3.0.CO;2-3. View

15.

Orr D, Fortenberry J, Blythe M . Validity of self-reported sexual behaviors in adolescent women using biomarker outcomes. Sex Transm Dis. 1997; 24(5):261-6. DOI: 10.1097/00007435-199705000-00005. View

16.

Koutsky L . Epidemiology of genital human papillomavirus infection. Am J Med. 1997; 102(5A):3-8. DOI: 10.1016/s0002-9343(97)00177-0. View

17.

Ho G, Bierman R, Beardsley L, Chang C, Burk R . Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 1998; 338(7):423-8. DOI: 10.1056/NEJM199802123380703. View

18.

Moscicki A, Shiboski S, Broering J, Powell K, Clayton L, Jay N . The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr. 1998; 132(2):277-84. DOI: 10.1016/s0022-3476(98)70445-7. View

19.

Gravitt P, Peyton C, Apple R, Wheeler C . Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol. 1998; 36(10):3020-7. PMC: 105104. DOI: 10.1128/JCM.36.10.3020-3027.1998. View

20.

Brown D, Schroeder J, Bryan J, Stoler M, Fife K . Detection of multiple human papillomavirus types in Condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol. 1999; 37(10):3316-22. PMC: 85555. DOI: 10.1128/JCM.37.10.3316-3322.1999. View